跳至主要内容
临床试验/NCT04536935
NCT04536935已完成不适用

Acceptability, Usability and Effectiveness of Mental Health Apps for Suicide Prevention in Essential Workers and the Unemployed During SARS-CoV-2

University of Washington2 个研究点 分布在 1 个国家目标入组 838 人开始时间: 2020年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
838
试验地点
2
主要终点
Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

Access to mental health care by essential workers and the unemployed during the COVID19 pandemic has been challenging. Usual access to mental health care is limited by social distancing, and for many now unemployed due to closures of businesses, insurance is insufficient to cover the costs of mental health care. For these individuals who are at risk for suicide (isolation, unemployment, financial crisis plus past suicide attempts, significant mental health challenges), access to care is crucial and many maybe turning to online and accessible interventions, such as mental health apps and other online resources. Indeed, organizations such as the VA have already created free access mobile applications for mental health in anticipation of this need. Using Psyberguide, the investigators will identify the top ten free apps that address mental health issues and conduct a nation-wide evaluation of these apps with participants who are essential workers and unemployed with risk for suicide. Participants will first be surveyed about which strategies they have used to manage mental health issues, what apps and online tools they have used, and what usability challenges they have faced. The investigators will then ask a random sample of participant to engage in a randomized trial of these top-rated apps for 4 weeks. Apps will be rated on usability, acceptability, feasibility and effectiveness. Results from this trial will be quickly disseminated through several avenues: (1) the UWAC website and ALACRITY Centers network; (2) through CREATIV Lab's partnership with Mental Health America; (3) through the UW Center for Suicide Prevention and Recovery (CSPAR) and partnerships with other suicide focused organizations including Forefront, the American Foundation for Suicide Prevention, that American Association of Suicidology, the Rocky Mountain MIRECC, and the Defense Suicide Prevention Office and (4) through local partnership with King County and WA state contact tracers.

详细描述

Participants will be recruited nationally via Prolific. Investigators will aim to recruit 1,000 participants in the clinical trial who are essential workers and/or unemployed due to COVID-19 and have a past history of mental health issues or experiencing suicide ideation motivational risk factors to be randomized (250 per group) to one of the four apps. They will be asked to download their assigned app and use it for 4 weeks. After 4 weeks of use, participants will be asked to provide an evaluation of acceptability, feasibility and usability of the app, how often they used the app, and if they found the app helpful. Participants will also be asked to complete clinical outcome measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 years old and older
  • Identify as an essential worker or unemployed due to COVID-19
  • English-speaking
  • Access to a mobile device (e.g. smartphone or tablet)
  • Based in the United States
  • 19 years old and older
  • Scored at or above validated cut off scores in Phase 1 (PHQ-2>3; GAD-2>3; SBQ-R>7) or reported history of past suicide attempt
  • Identify as an essential worker or unemployed due to COVID-19
  • English-speaking
  • Access to a mobile device (e.g. smartphone or tablet)
  • Based in the United States

排除标准

  • Under the age of 19
  • Neither an essential worker nor unemployed due to COVID-19
  • Non-English speaking
  • No access to a mobile device (e.g. smartphone or tablet)
  • Not based in the United States
  • Under the age of 19
  • Did not score at or above validated cut off scores in Phase 1 (PHQ-2>3; GAD-2>3; SBQ-R>7) nor reported history of past suicide attempt
  • Neither an essential worker nor unemployed due to COVID-19
  • Non-English speaking
  • No access to a mobile device (e.g. smartphone or tablet)
  • Not based in the United States

结局指标

主要结局

Patient Health Questionnaire (PHQ-9)

时间窗: PHQ-9 at RCT baseline and RCT follow-up; duration of 4 weeks.

The Patient Health Questionnaire (PHQ-9) consists of 9 depression items and one disability item. Each item is associated with a DSM symptom of depression, which the participant rates whether or not they have experienced the symptom over the last two weeks, with severity rating of 0-3. It is one of the few measures that is brief (it takes less than one minute to give) and has been found to have excellent sensitivity to change over time, with a total sum score ranging from 0 - 27. Higher scores indicate higher depression symptom severity.

Generalized Anxiety Disorder (7-Item) Scale (GAD-7)

时间窗: GAD-7 at RCT baseline and RCT follow-up; duration of 4 weeks.

The Generalized Anxiety Disorder Scale (GAD-7) is a 7- item screener for generalized anxiety. It consists of items related to generalized anxiety disorder. Participants rate on a scale of 0-3 how much they have experienced in the last two weeks to crease a total sum score ranging from 0 - 21. The scale is a valid screener for generalized anxiety symptoms. Higher scores indicate higher anxiety symptom severity.

Brief Difficulties With Emotional Regulation Scale (DERS)

时间窗: DERS at RCT baseline and RCT follow-up; duration of four weeks.

The Brief Difficulties with Emotional Regulation Scale (DERS) is a brief, 36-item, self-report questionnaire designed to assess multiple aspects of emotion dysregulation. a 36-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Total scores range from 18 - 90 with higher scores indicate more difficulty in emotion regulation.

Suicidal Behavioral Questionnaire-Revised (SBQ-R)

时间窗: SBQ-R RCT baseline and RCT follow-up; duration of four weeks.

The suicidal behavioral questionnaire revised (SBQ-R) is a self-report questionnaire designed to identify risk factors for suicide. Total scores range from 3 to 18, with higher scores indicate indicating higher risk of suicidal behavior.

次要结局

  • Intervention Appropriateness Measure (IAM)(Participants will complete this measure at RCT Follow-Up; after 4 weeks of using the mobile mental health app to which they are randomized.)
  • Intervention Usability Scale (IUS)(Participants will complete this measure at RCT Follow-Up; after 4 weeks of using the mobile mental health app to which they are randomized.)
  • Acceptability of Intervention Measure (AIM)(Participants will complete this measure at RCT Follow-Up; after 4 weeks of using the mobile mental health app to which they are randomized.)
  • Feasibility of Intervention Measure (FIM)(Participants will complete this measure at RCT Follow-Up; after 4 weeks of using the mobile mental health app to which they are randomized.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kate Comtois

Professor

University of Washington

研究点 (2)

Loading locations...

相似试验